Annual CFF
$20.07 M
+$17.17 M+591.73%
30 April 2024
Summary:
Avid Bioservices annual cash flow from financing activities is currently $20.07 million, with the most recent change of +$17.17 million (+591.73%) on 30 April 2024. During the last 3 years, it has fallen by -$92.27 million (-82.14%). CDMO annual CFF is now -82.14% below its all-time high of $112.33 million, reached on 30 April 2021.CDMO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$266.00 K
-$11.57 M-97.75%
31 July 2024
Summary:
Avid Bioservices quarterly cash flow from financing activities is currently $266.00 thousand, with the most recent change of -$11.57 million (-97.75%) on 31 July 2024. Over the past year, it has dropped by -$7.13 million (-96.41%). CDMO quarterly CFF is now -99.69% below its all-time high of $85.31 million, reached on 30 April 2021.CDMO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$19.59 M
-$482.00 K-2.40%
31 July 2024
Summary:
Avid Bioservices TTM cash flow from financing activities is currently $19.59 million, with the most recent change of -$482.00 thousand (-2.40%) on 31 July 2024. Over the past year, it has increased by +$9.87 million (+101.49%). CDMO TTM CFF is now -83.68% below its all-time high of $120.01 million, reached on 31 October 2021.CDMO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDMO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +591.7% | -96.4% | +101.5% |
| 3 y3 years | -82.1% | -73.5% | -83.7% |
| 5 y5 years | +800.9% | +136.9% | +656.2% |
CDMO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -82.1% | +591.7% | -97.8% | +212.9% | -83.7% | +729.9% |
| 5 y | 5 years | -82.1% | +800.9% | -99.7% | +105.0% | -83.7% | +656.2% |
| alltime | all time | -82.1% | +800.9% | -99.7% | +105.0% | -83.7% | +640.6% |
Avid Bioservices Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | $266.00 K(-97.8%) | $19.59 M(-2.4%) |
| Apr 2024 | $20.07 M(+591.7%) | $11.83 M(>+9900.0%) | $20.07 M(+124.5%) |
| Jan 2024 | - | $85.00 K(-98.9%) | $8.94 M(-8.1%) |
| Oct 2023 | - | $7.40 M(+889.3%) | $9.72 M(+257.4%) |
| July 2023 | - | $748.00 K(+6.3%) | $2.72 M(-6.2%) |
| Apr 2023 | $2.90 M(-9.3%) | $704.00 K(-18.9%) | $2.90 M(+22.9%) |
| Jan 2023 | - | $868.00 K(+117.0%) | $2.36 M(-9.3%) |
| Oct 2022 | - | $400.00 K(-56.9%) | $2.60 M(-18.9%) |
| July 2022 | - | $929.00 K(+469.9%) | $3.21 M(+0.3%) |
| Apr 2022 | $3.20 M(-97.2%) | $163.00 K(-85.3%) | $3.20 M(-96.4%) |
| Jan 2022 | - | $1.11 M(+10.5%) | $88.34 M(-26.4%) |
| Oct 2021 | - | $1.00 M(+9.5%) | $120.01 M(+1.2%) |
| July 2021 | - | $918.00 K(-98.9%) | $118.54 M(+5.5%) |
| Apr 2021 | $112.33 M(>+9900.0%) | $85.31 M(+160.3%) | $112.33 M(+270.2%) |
| Jan 2021 | - | $32.78 M(-7194.8%) | $30.34 M(-1100.4%) |
| Oct 2020 | - | -$462.00 K(-91.3%) | -$3.03 M(-7.9%) |
| July 2020 | - | -$5.29 M(-259.5%) | -$3.29 M(-400.4%) |
| Apr 2020 | $1.10 M(-138.3%) | $3.31 M(-655.3%) | $1.10 M(-135.7%) |
| Jan 2020 | - | -$597.00 K(-17.2%) | -$3.07 M(-12.9%) |
| Oct 2019 | - | -$721.00 K(-20.0%) | -$3.52 M(-2.8%) |
| July 2019 | - | -$901.00 K(+6.4%) | -$3.62 M(+26.5%) |
| Apr 2019 | -$2.86 M(-112.9%) | -$847.00 K(-19.5%) | -$2.86 M(-115.2%) |
| Jan 2019 | - | -$1.05 M(+27.8%) | $18.85 M(-1.2%) |
| Oct 2018 | - | -$823.00 K(+483.7%) | $19.08 M(+0.2%) |
| July 2018 | - | -$141.00 K(-100.7%) | $19.04 M(-14.4%) |
| Apr 2018 | $22.25 M(-21.0%) | $20.87 M(-2641.7%) | $22.25 M(+14.8%) |
| Jan 2018 | - | -$821.00 K(-5.1%) | $19.38 M(-22.1%) |
| Oct 2017 | - | -$865.00 K(-128.2%) | $24.87 M(-17.5%) |
| July 2017 | - | $3.07 M(-82.9%) | $30.16 M(+7.1%) |
| Apr 2017 | $28.16 M(-32.6%) | $17.99 M(+284.9%) | $28.16 M(+155.2%) |
| Jan 2017 | - | $4.67 M(+5.9%) | $11.04 M(-12.6%) |
| Oct 2016 | - | $4.42 M(+308.9%) | $12.63 M(-62.8%) |
| July 2016 | - | $1.08 M(+24.6%) | $33.92 M(-18.8%) |
| Apr 2016 | $41.79 M(+19.5%) | $867.00 K(-86.2%) | $41.79 M(-31.4%) |
| Jan 2016 | - | $6.27 M(-75.6%) | $60.88 M(+6.8%) |
| Oct 2015 | - | $25.70 M(+187.2%) | $57.00 M(+64.3%) |
| July 2015 | - | $8.95 M(-55.1%) | $34.69 M(-0.8%) |
| Apr 2015 | $34.98 M(-52.1%) | $19.95 M(+734.5%) | $34.98 M(-4.4%) |
| Jan 2015 | - | $2.39 M(-29.5%) | $36.60 M(-40.7%) |
| Oct 2014 | - | $3.39 M(-63.3%) | $61.75 M(-8.6%) |
| July 2014 | - | $9.24 M(-57.2%) | $67.53 M(-7.6%) |
| Apr 2014 | $73.06 M(+88.1%) | $21.58 M(-21.6%) | $73.06 M(+12.1%) |
| Jan 2014 | - | $27.54 M(+200.3%) | $65.16 M(+41.0%) |
| Oct 2013 | - | $9.17 M(-37.9%) | $46.21 M(-11.5%) |
| July 2013 | - | $14.77 M(+8.0%) | $52.19 M(+34.4%) |
| Apr 2013 | $38.85 M(+21.4%) | $13.68 M(+59.1%) | $38.85 M(+20.3%) |
| Jan 2013 | - | $8.60 M(-43.3%) | $32.28 M(-5.3%) |
| Oct 2012 | - | $15.15 M(+964.2%) | $34.08 M(+12.2%) |
| July 2012 | - | $1.42 M(-80.0%) | $30.36 M(-5.1%) |
| Apr 2012 | $32.01 M(+2.6%) | $7.11 M(-31.6%) | $32.01 M(+2.5%) |
| Jan 2012 | - | $10.39 M(-9.2%) | $31.21 M(-9.9%) |
| Oct 2011 | - | $11.44 M(+272.9%) | $34.64 M(+21.9%) |
| July 2011 | - | $3.07 M(-51.4%) | $28.41 M(-8.9%) |
| Apr 2011 | $31.20 M(+30.6%) | $6.32 M(-54.3%) | $31.20 M(-2.4%) |
| Jan 2011 | - | $13.82 M(+165.0%) | $31.95 M(+34.0%) |
| Oct 2010 | - | $5.21 M(-11.0%) | $23.84 M(+2.2%) |
| July 2010 | - | $5.86 M(-17.1%) | $23.33 M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2010 | $23.89 M(+372.4%) | $7.07 M(+23.8%) | $23.89 M(+37.6%) |
| Jan 2010 | - | $5.71 M(+21.4%) | $17.37 M(+7.3%) |
| Oct 2009 | - | $4.70 M(-26.8%) | $16.19 M(+41.0%) |
| July 2009 | - | $6.42 M(+1079.6%) | $11.48 M(+127.0%) |
| Apr 2009 | $5.06 M(-75.4%) | $544.00 K(-88.0%) | $5.06 M(+12.1%) |
| Jan 2009 | - | $4.53 M(<-9900.0%) | $4.51 M(-3955.6%) |
| Oct 2008 | - | -$5000.00(-16.7%) | -$117.00 K(-48.7%) |
| July 2008 | - | -$6000.00(+100.0%) | -$228.00 K(-101.1%) |
| Apr 2008 | $20.59 M(+18.2%) | -$3000.00(-97.1%) | $20.59 M(+0.5%) |
| Jan 2008 | - | -$103.00 K(-11.2%) | $20.48 M(-5.5%) |
| Oct 2007 | - | -$116.00 K(-100.6%) | $21.68 M(-1.0%) |
| July 2007 | - | $20.82 M(<-9900.0%) | $21.90 M(+25.7%) |
| Apr 2007 | $17.42 M(-27.1%) | -$114.00 K(-110.4%) | $17.42 M(-24.9%) |
| Jan 2007 | - | $1.09 M(+972.5%) | $23.20 M(-19.7%) |
| Oct 2006 | - | $102.00 K(-99.4%) | $28.90 M(+0.5%) |
| July 2006 | - | $16.34 M(+188.4%) | $28.76 M(+20.4%) |
| Apr 2006 | $23.88 M(+157.1%) | $5.67 M(-16.6%) | $23.88 M(+11.5%) |
| Jan 2006 | - | $6.79 M(<-9900.0%) | $21.42 M(+10.3%) |
| Oct 2005 | - | -$43.00 K(-100.4%) | $19.42 M(-6.2%) |
| July 2005 | - | $11.47 M(+258.1%) | $20.70 M(+122.8%) |
| Apr 2005 | $9.29 M(-60.7%) | $3.20 M(-33.2%) | $9.29 M(+19.0%) |
| Jan 2005 | - | $4.79 M(+286.8%) | $7.81 M(-28.6%) |
| Oct 2004 | - | $1.24 M(+2073.7%) | $10.93 M(-32.7%) |
| July 2004 | - | $57.00 K(-96.7%) | $16.25 M(-31.3%) |
| Apr 2004 | $23.66 M(+213.7%) | $1.72 M(-78.3%) | $23.66 M(+7.8%) |
| Jan 2004 | - | $7.92 M(+20.7%) | $21.94 M(+62.5%) |
| Oct 2003 | - | $6.56 M(-12.2%) | $13.50 M(-10.2%) |
| July 2003 | - | $7.47 M(>+9900.0%) | $15.03 M(+99.2%) |
| Apr 2003 | $7.54 M(-43.2%) | $3000.00(-100.6%) | $7.54 M(-2.6%) |
| Jan 2003 | - | -$524.00 K(-106.5%) | $7.75 M(-52.5%) |
| Oct 2002 | - | $8.08 M(<-9900.0%) | $16.31 M(+55.1%) |
| July 2002 | - | -$18.00 K(-108.8%) | $10.51 M(-20.8%) |
| Apr 2002 | $13.28 M(+53.5%) | $205.00 K(-97.4%) | $13.28 M(+13.6%) |
| Jan 2002 | - | $8.04 M(+251.2%) | $11.70 M(+222.2%) |
| Oct 2001 | - | $2.29 M(-16.8%) | $3.63 M(+64.9%) |
| July 2001 | - | $2.75 M(-299.0%) | $2.20 M(-74.6%) |
| Apr 2001 | $8.65 M(-22.8%) | -$1.38 M(+5018.5%) | $8.65 M(-39.6%) |
| Jan 2001 | - | -$27.00 K(-103.1%) | $14.33 M(-17.9%) |
| Oct 2000 | - | $860.00 K(-90.7%) | $17.46 M(-4.1%) |
| July 2000 | - | $9.20 M(+114.0%) | $18.20 M(+62.5%) |
| Apr 2000 | $11.20 M(+107.4%) | $4.30 M(+38.7%) | $11.20 M(+25.8%) |
| Jan 2000 | - | $3.10 M(+93.8%) | $8.90 M(+117.1%) |
| Oct 1999 | - | $1.60 M(-27.3%) | $4.10 M(+70.8%) |
| July 1999 | - | $2.20 M(+10.0%) | $2.40 M(-55.6%) |
| Apr 1999 | $5.40 M(+134.8%) | $2.00 M(-217.6%) | $5.40 M(+3.8%) |
| Jan 1999 | - | -$1.70 M(+1600.0%) | $5.20 M(-24.6%) |
| Oct 1998 | - | -$100.00 K(-101.9%) | $6.90 M(0.0%) |
| July 1998 | - | $5.20 M(+188.9%) | $6.90 M(+200.0%) |
| Apr 1998 | $2.30 M(-81.3%) | $1.80 M(>+9900.0%) | $2.30 M(-80.7%) |
| Jan 1998 | - | $0.00(-100.0%) | $11.90 M(+0.8%) |
| Oct 1997 | - | -$100.00 K(-116.7%) | $11.80 M(-8.5%) |
| July 1997 | - | $600.00 K(-94.7%) | $12.90 M(+4.9%) |
| Apr 1997 | $12.30 M(+26.8%) | $11.40 M(<-9900.0%) | $12.30 M(+1266.7%) |
| Jan 1997 | - | -$100.00 K(-110.0%) | $900.00 K(-10.0%) |
| Oct 1996 | - | $1.00 M(>+9900.0%) | $1.00 M(>+9900.0%) |
| July 1996 | - | $0.00 | $0.00 |
| Apr 1996 | $9.70 M(+546.7%) | - | - |
| Apr 1995 | $1.50 M | - | - |
FAQ
- What is Avid Bioservices annual cash flow from financing activities?
- What is the all time high annual CFF for Avid Bioservices?
- What is Avid Bioservices annual CFF year-on-year change?
- What is Avid Bioservices quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Avid Bioservices?
- What is Avid Bioservices quarterly CFF year-on-year change?
- What is Avid Bioservices TTM cash flow from financing activities?
- What is the all time high TTM CFF for Avid Bioservices?
- What is Avid Bioservices TTM CFF year-on-year change?
What is Avid Bioservices annual cash flow from financing activities?
The current annual CFF of CDMO is $20.07 M
What is the all time high annual CFF for Avid Bioservices?
Avid Bioservices all-time high annual cash flow from financing activities is $112.33 M
What is Avid Bioservices annual CFF year-on-year change?
Over the past year, CDMO annual cash flow from financing activities has changed by +$17.17 M (+591.73%)
What is Avid Bioservices quarterly cash flow from financing activities?
The current quarterly CFF of CDMO is $266.00 K
What is the all time high quarterly CFF for Avid Bioservices?
Avid Bioservices all-time high quarterly cash flow from financing activities is $85.31 M
What is Avid Bioservices quarterly CFF year-on-year change?
Over the past year, CDMO quarterly cash flow from financing activities has changed by -$7.13 M (-96.41%)
What is Avid Bioservices TTM cash flow from financing activities?
The current TTM CFF of CDMO is $19.59 M
What is the all time high TTM CFF for Avid Bioservices?
Avid Bioservices all-time high TTM cash flow from financing activities is $120.01 M
What is Avid Bioservices TTM CFF year-on-year change?
Over the past year, CDMO TTM cash flow from financing activities has changed by +$9.87 M (+101.49%)